biomarker detection
Cofactor Quickly Moving Immunotherapy Predictive Test to Market With Data From Intermountain Spinout
Premium
Culmination Bio's 4.5 million biospecimens and longitudinal omics and clinical data may help Cofactor rapidly advance the OncoPrism assay into multiple cancer types.
Epic Sciences Raises $24M, Expands Commercial Infrastructure for Breast Cancer Liquid Biopsy Test
The firm is growing its sales, product marketing, and customer service teams for its multiomic metastatic breast cancer liquid biopsy test, DefineMBC.
With $13 million in new funding in hand, the small bioinformatics company aims to take on Big Pharma and will look to partner with major molecular labs.
Biosensor Startup Monod Bio Raises $25M
The funding will be used to advance the company's LucCage platform for the rapid development of one-step biosensors and reporter proteins.
Paige Obtains CE Mark, UK Regulatory Approval for Prostate Cancer AI Software
Paige said the approvals represent its first European regulatory certifications for image-based biomarker detection on H&E-stained tissue samples.